We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 839 results
  1. Machado-Joseph disease in a Sudanese family links East Africa to Portuguese families and allows reestimation of ancestral age of the Machado lineage

    Machado-Joseph disease (MJD/SCA3) is the most frequent dominant ataxia worldwide. It is caused by a (CAG) n expansion. MJD has two major ancestral...

    Sandra Martins, Ashraf Yahia, ... Jorge Sequeiros in Human Genetics
    Article Open access 14 November 2023
  2. Machado Joseph-Disease Is Rare in the Peruvian Population

    Spinocerebellar ataxia type 3 or Machado-Joseph disease (MJD/SCA3) is the most prevalent autosomal dominant cerebellar ataxia worldwide, but its...

    Mario Cornejo-Olivas, Lesly Solis-Ponce, ... Elison Sarapura-Castro in The Cerebellum
    Article 03 November 2022
  3. “I Do Not Know How You Feel and How I Feel About That”: Mentalizing Impairments in Machado-Joseph Disease

    Machado Joseph disease (MJD), also known as spinocerebellar ataxia type 3 (SCA3), is an autosomal dominant neurodegenerative disease. Mentalizing is...

    Zohar Elyoseph, Dario Geisinger, ... Carlos R. Gordon in The Cerebellum
    Article 28 February 2023
  4. Horizontal Vestibulo-Ocular Reflex Deficit as a Biomarker for Clinical Disease Onset, Severity, and Progression of Machado-Joseph Disease

    Because of the crucial importance of finding a useful biomarker for further clinical trials in Machado-Joseph disease (MJD), and based on our...

    Zohar Elyoseph, Dario Geisinger, ... Carlos R. Gordon in The Cerebellum
    Article 28 March 2023
  5. Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease

    Machado-Joseph disease (MJD) or Spinocerebellar ataxia type 3 (SCA3) is the most common form of dominant SCA worldwide. Magnetic Resonance Imaging...

    Catarina Oliveira Miranda, Rui Jorge Nobre, ... Luís Pereira de Almeida in Acta Neuropathologica Communications
    Article Open access 19 March 2022
  6. Short Communication: Restrictions in care following the COVID-19 pandemic severely impacted Machado-Joseph disease patients: a study in the Azores Islands, Portugal

    This qualitative study describes how the restrictions imposed by the COVID-19 pandemic impacted on Machado-Joseph disease (MJD) patients and their...

    Daniela Couto, Liliana Sousa, ... Álvaro Mendes in Journal of Community Genetics
    Article 18 July 2022
  7. Caffeine Consumption and Interaction with ADORA2A, CYP1A2 and NOS1 Variants Do Not Influence Age at Onset of Machado-Joseph Disease

    Background

    The age at onset (AO) of Machado-Joseph disease (SCA3/MJD), a disorder due to an expanded CAG repeat (CAGexp) in ATXN3 , is quite variable...

    Ana Carolina Martins, Jordânia dos Santos Pinheiro, ... Laura Bannach Jardim in The Cerebellum
    Article 06 July 2024
  8. Diagnostic Delay of Hereditary Ataxias in Brazil: the Case of Machado-Joseph Disease

    Background

    Spinocerebellar ataxia type 3/Machado-Joseph disease (SCA3/MJD) is a rare disease with diagnosis offered by the Unified Health System in...

    Jordânia dos Santos Pinheiro, Lucas Schenatto Sena, ... Laura Bannach Jardim in The Cerebellum
    Article 14 April 2022
  9. Altered glucose metabolism and its association with carbonic anhydrase 8 in Machado-Joseph Disease

    Machado-Joseph disease (MJD), also known as spinocerebellar ataxia type 3 (SCA3), is an autosomal dominant neurodegenerative disease. This disorder...

    Guan-Yu Lin, Chung-Yung Ma, ... Mingli Hsieh in Metabolic Brain Disease
    Article 30 April 2022
  10. Remote Measurement of Functional Status in Pre-symptomatic and Symptomatic Individuals with Machado-Joseph Disease

    Elaine Cristina Miglorini, Victor Henrique Ignácio de Souza, ... Laura Bannach Jardim in The Cerebellum
    Article 29 March 2022
  11. Quality of Life since Pre-Ataxic Phases of Spinocerebellar Ataxia Type 3/Machado–Joseph Disease

    Although health-related quality of life (HRQoL) has been increasingly valued in healthcare and in clinical trials, there is scarce information about...

    Gabriela Bolzan, Vanessa Bielefeldt Leotti, ... Laura Bannach Jardim in The Cerebellum
    Article 06 July 2021
  12. Genetic Variation in ATXN3 (Ataxin-3) 3′UTR: Insights into the Downstream Regulatory Elements of the Causative Gene of Machado-Joseph Disease/Spinocerebellar Ataxia Type 3

    Untranslated regions are involved in the regulation of transcriptional and post-transcriptional processes. Characterization of these regions remains...

    Ana Rosa Vieira Melo, Mafalda Raposo, ... Manuela Lima in The Cerebellum
    Article 16 January 2022
  13. Trehalose in Machado-Joseph Disease: Safety, Tolerability, and Efficacy

    Machado-Joseph disease (MJD) is relatively prevalent among the Yemenite Jewish subpopulation living in Israel. Currently, there is no treatment able...

    Roy Zaltzman, Zohar Elyoseph, ... Carlos R. Gordon in The Cerebellum
    Article 09 June 2020
  14. Trehalose alleviates the phenotype of Machado–Joseph disease mouse models

    Background

    Machado–Joseph disease (MJD), also known as spinocerebellar ataxia type 3, is the most common of the dominantly inherited ataxias worldwide...

    Magda M. Santana, Susana Paixão, ... Luís Pereira de Almeida in Journal of Translational Medicine
    Article Open access 09 April 2020
  15. The blood-brain barrier is disrupted in Machado-Joseph disease/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples

    Blood-brain barrier (BBB) disruption is a common feature in neurodegenerative diseases. However, BBB integrity has not been assessed in...

    Diana Duarte Lobo, Rui Jorge Nobre, ... Luís Pereira de Almeida in Acta Neuropathologica Communications
    Article Open access 31 August 2020
  16. Yemenite-Jewish families with Machado–Joseph disease (MJD/SCA3) share a recent common ancestor

    In 1994, a kindred from Yemen was described as the first Jewish family with Machado–Joseph disease (MJD/SCA3), a dominant ataxia caused by the...

    Reuven Sharony, Sandra Martins, ... Carlos R. Gordon in European Journal of Human Genetics
    Article 12 June 2019
  17. Variation in DNA Repair System Gene as an Additional Modifier of Age at Onset in Spinocerebellar Ataxia Type 3/Machado–Joseph Disease

    Spinocerebellar ataxia type 3, or Machado–Joseph disease (SCA3/MJD), is caused by an expansion of CAG repeats, which is inversely correlated to age...

    Rafaella Mergener, Gabriel Vasata Furtado, ... Maria Luiza Saraiva-Pereira in NeuroMolecular Medicine
    Article 05 October 2019
  18. Prevalence of repeat expansions causing autosomal dominant spinocerebellar ataxias in Hokkaido, the northernmost island of Japan

    In Japan, approximately 30% of spinocerebellar degeneration (SCD) is hereditary, and more than 90% of hereditary SCD is autosomal dominant SCD...

    Keiichi Mizushima, Yuka Shibata, ... Ichiro Yabe in Journal of Human Genetics
    Article 17 October 2023
  19. Antisense Oligonucleotide Therapy Against SCA3

    Spinocerebellar ataxia type 3 (SCA3), also known as Machado Joseph disease, is a dominantly inherited neurodegenerative disease that has remained, to...
    Hayley S. McLoughlin in Trials for Cerebellar Ataxias
    Chapter 2023
  20. The Ubiquitin–Proteasome System and Cerebellar Developmental Disease

    A variety of developmental diseases of the cerebellum are associated with the dysregulation of proteins regulated by the ubiquitin–proteasome system...
    Chapter 2023
Did you find what you were looking for? Share feedback.